Tuesday, 22 May 2012

The biopharmaceutical industry is focusing on the growing complexity of licensing deals in order to secure marketing and commercialization rights within partnership deals. The major challenge faced by the biopharmaceutical licensing market is asymmetry between licensor and licensees. The biopharmaceutical licensing industry is growing in popularity as large companies are becoming heavily dependent on alliances and licensing to gain access to newer technologies in the biopharmaceutical market.

This dependence has strengthened the bargaining position of smaller players as they are willing to expand their role beyond product discovery and development towards active participation in the biopharmaceutical products industry. 
This research report on the biopharmaceutical licensing market analyzes its market segments and major geographies. The major regions analyzed under this research study are 
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World 
This report provides a comprehensive analysis of market trends, industry growth drivers, restraints, market structure, and market projections for the coming years. It also includes an analysis of the technological developments in the biopharmaceutical licensing industry, Porter’s five force model analysis, and detailed company profiles of the top industry players. It provides a review of the micro and macro factors significant for the existing market players and new entrants along with detailed value chain analysis. 
Key players dominating this industry are Intas Pharmaceuticals Ltd., Pfizer, Merck & Co., GlaxoSmithKline, Johnson & Johnson, Bayer AG, Novartis, Hoffman La-Roche, Sanofi, AstraZeneca, Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly & Company, Schering-Plough, Baxter International, Genentech, Proctor & Gamble, Boehringer Ingelheim, and others.

Reasons for Buying this Report 
  • This research report provides an overview of the different factors responsible for driving and limiting market growth 
  • It provides a complete analysis of the major competitors and their business strategies and helps to get a proper insight of the market
  • It helps to make informed business decisions based on the in-depth analysis of industry trends 
  • It provides a clear understanding of the key product segments and helps to stay ahead in the competition 
  • It provides a technological growth map over a time and explains its impact on the market 
Read More with Full TOC :  http://www.transparencymarketresearch.com/biopharmaceutical-licensing-market.html


Post a Comment